Accès gratuit
Numéro
Biologie Aujourd'hui
Volume 207, Numéro 2, 2013
Journée Claude Bernard 2012
Page(s) 87 - 95
DOI https://doi.org/10.1051/jbio/2013009
Publié en ligne 10 octobre 2013
  • Baudouin C., Liang H., Hamard P., Riancho L., Creuzot-Garcher C., Warnet J.M., Brignole-Baudouin F., The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology, 2008, 115, 109–115. [CrossRef] [PubMed] [Google Scholar]
  • Baudouin C., Labbé A., Liang H., Pauly A., Brignole-Baudouin F., Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res, 2010, 29, 312-334. [CrossRef] [PubMed] [Google Scholar]
  • Baudouin C., Denoyer A., Desbenoit N., Hamm G., Grise A., In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc, 2012, 110, 40–53. [PubMed] [Google Scholar]
  • Bernauer W., Ocular surface problems following topical medication. Klin Monatsbl Augenheilkd, 2002, 219, 240–242. [CrossRef] [Google Scholar]
  • Brignole-Baudouin F., Desbenoit N., Hamm G., Liang H., Both J.P., Brunelle A., Fournier I., Guérineau V., Legouffe R., Stauber J., Touboul D., Wisztorski M., Salzet M., Laprévote O., Baudouin C., A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye. An experimental study in rabbits. PLoS One, 2012, 7, e50180. [CrossRef] [PubMed] [Google Scholar]
  • Champeau E., Edelhauser H., Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. 1986. In: Holly, F. (Ed.), The preocular tear film. Dry Eye Institute, Inc, Lubbock, TX, pp. 292–302. [Google Scholar]
  • Clouzeau C., Godefroy D., Riancho L., Rostène W., Baudouin C., Brignole-Baudouin F., Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis, 2012, 18, 851–863. [PubMed] [Google Scholar]
  • Denoyer A., Godefroy D., Célérier I., Frugier J., Degardin J., Harrison J.K., Brignole-Baudouin F., Picaud S., Baleux F., Sahel J.A., Rostène W., Baudouin C., CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension. PLoS One, 2012, 7, e37873. [CrossRef] [PubMed] [Google Scholar]
  • Krupin T., Liebmann J.M., Greenfield D.S., Ritch R., Gardiner S., Low-Pressure Glaucoma Study Group. A randomized trial of brimonidine versus timolol in preserving visual function : results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol, 2011, 151, 671–681. [CrossRef] [PubMed] [Google Scholar]
  • Quigley H.A., Broman A.T., The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol, 2006, 90, 262–267. [Google Scholar]
  • Rostène W., Dansereau M.A., Godefroy D., Van Steenwinckel J., Réaux-Le Goazigo A., Mélik-Parsadaniantz S., Apartis E., Hunot S., Beaudet N., Sarret P., Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem, 2011, 118, 680–694. [CrossRef] [PubMed] [Google Scholar]
  • Singh A.K., Arya R.K., Trivedi A.K., Sanyal S., Baral R., Dormond O., Briscoe D.M., Datta D., Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine Growth Factor Rev, 2013, 24, 41–49. [CrossRef] [PubMed] [Google Scholar]
  • Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Ollenberg M.D., Jhamandas J.H., Overall C.M., Power C., Proteolytic processing of SDF-1a reveals a change in receptor specificity mediating HIV-associated neurodegeneration. PNAS, 2006, 103, 1982–1987. [CrossRef] [Google Scholar]
  • Yu A.L., Birke K., Moriniere J., Welge-Lüssen U., TGF-{beta} 2 induces senescence-associated changes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci, 2010, 51, 5718–5723. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.